Paws Raises INR 29.3 Crore Pre-Series A Led by Chiratae Ventures
bolt Executive Summary
- Bengaluru-based Dr. Paws raised INR 29.3 crore in pre-Series A funding. Chiratae Ventures led the round with Sauce joining. Trifecta Capital and Stride Ventures provided venture debt.
- View source
Bengaluru-based Dr. Paws raised INR 29.3 crore in pre-Series A funding. Chiratae Ventures led the round with Sauce joining. Trifecta Capital and Stride Ventures provided venture debt.
Funding details: INR 29.3 crore - Pre-Series A (Unspecified)
Full Story
Dr. Paws closed INR 29.3 crore in a pre-Series A round.
Chiratae Ventures led the funding. Existing backer Sauce took part again. There was also venture debt from Trifecta Capital and Stride Ventures.
The money will help add nine new clinics in Bengaluru by 2026. The company also plans to open in Hyderabad and Pune. It will start at-home vet services and its own products like treats, supplements, and pet food.
The team will put some cash into tech for better workflows, customer tools, and training. They are also adding people to the leadership team for city and central roles.
Dr. Paws runs veterinary clinics in Bengaluru. The clinics handle consultations, surgeries, diagnostics, and preventive care for pets. The company now has three 24x7 locations open and two more coming soon.
Source:- Entrackr.
Filed Under
Recommended next
View all
OpenAI acquires health-tech startup Torch for over USD 100 million
OpenAI has acquired US-based health-tech startup Torch. The deal is valued at more than USD 100 million and strengthens OpenAI’s push into healthcare.
Earthful Raises INR 26 Crore Pre-Series A Funding
Hyderabad-based Earthful raised INR 26 crore in pre-Series A funding. Fireside Ventures and V3 Ventures led the round. Atrium Angels joined in.
PsiThera raises $47.5 million Series A, names new CEO
PsiThera closed a $47.5 million Series A round. Samsara Biocapital and Lightstone Ventures led. Eric Shaff joins as new CEO.
EpilepsyGTx raises $33 million Series A for epilepsy gene therapy
EpilepsyGTx raised $33 million in Series A funding. XGEN Venture, British Business Bank invested. Funds advance EPY201 through Phase I/IIa trials.
Stay ahead of the curve
Get the latest business and tech insights delivered to your inbox daily.